Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03473249 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Contrast-Enhanced Ultrasound
A Phase 4 study of Accidental Fall and Physical Abuse, sponsored by Children's Hospital of Philadelphia.
- Active
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT03473249: Active Phase 4 study of Accidental Fall and Physical Abuse, sponsored by Children's Hospital of Philadelphia.
NCT03473249 is a Phase 4 study of Accidental Fall and Physical Abuse that is active but no longer recruiting, run by Children's Hospital of Philadelphia. The registered enrollment target is 120 participants, below the 250-participant average among 9 other Accidental Fall trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03473249, a Phase 4 study of Accidental Fall and Physical Abuse, is active but no longer recruiting, sponsored by Children's Hospital of Philadelphia.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to generate pilot data describing test characteristics of contrast enhanced ultrasound in young children with concern for abdominal trauma. The primary objective in this study is to determine the sensitivity and specificity of contrast-enhanced ultrasound (CEUS) compared to abdominal Computed Tomography (CT) in the detection of abdominal solid organ injury in young children \< 8 years of age with concern for blunt abdominal trauma.
Primary Outcome
To determine the sensitivity of contrast-enhanced ultrasound (CEUS) compared with standard, abdominal Computer Tomography (CT) in the detection of abdominal solid organ injury in young children \< 8 years of age with concern for blunt abdominal trauma.
Conditions Studied
Interventions
- DRUG Contrast-Enhanced Ultrasound using Lumason
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-05-09 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
What the registry record for NCT03473249 still lists
NCT03473249 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 250-participant average among 9 other Accidental Fall trials with a reported enrollment target (52% lower).
The record links to 4 conditions, with Accidental Fall appearing as the primary indexed condition, and to 1 intervention - of which Contrast-Enhanced Ultrasound using Lumason is the first listed.
NCT03473249 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03473249 about?
NCT03473249 is a clinical study titled "Effectiveness of Contrast-Enhanced Ultrasound". The purpose of the study is to generate pilot data describing test characteristics of contrast enhanced ultrasound in young children with concern for abdominal trauma. The primary objective in this study is to determine the sensitivity and specificity of contrast-enhanced ultrasound (CEUS) compared ...
What is the current status of trial NCT03473249?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2018-05-09. Estimated completion is 2026-12.
What conditions does trial NCT03473249 study?
This clinical trial studies the following conditions: Accidental Fall, Physical Abuse, Abdominal Injuries, Motor Vehicle Injury.
What interventions are being tested in trial NCT03473249?
The interventions under investigation include: Contrast-Enhanced Ultrasound using Lumason (DRUG).
Who is sponsoring clinical trial NCT03473249?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03473249 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Accidental Fall
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03473249's enrollment target sits among peer trials
120 5th of 9 higher than 5 of 9 other Accidental Fall trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Accidental Fall trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults
RECRUITING · NA
-
Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals
RECRUITING · NA
-
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
ACTIVE NOT RECRUITING · Phase 1
-
TRAIN-BW: Backward Walking Training in Multiple Sclerosis
ACTIVE NOT RECRUITING · NA
-
Standing Balance as the Fifth Vital Sign in Clinical Setting
COMPLETED
-
Fall Prevention in Older Adults Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI